1.Combined therapy with daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b: a case report.
Journal of Southern Medical University 2016;36(8):1163-1164
The combination therapy with daclatasvir and asunaprevir can achieve a high sustained viral response rate against hepatitis C virus (HCV) genotype 1, but so far this regimen has not been reported in the treatment of Chinese patients with chronic hepatitis C (CHC) genotype 1b. Here we report a case of CHC genotype 1b in a 44-year-old female chinese patient who was treated with this regimen for 24 weeks. The patient showed sustained viral response after the treatment and was clinically cured. During the treatment, the patient experienced a transient elevation of serum total bilirubin accompanied by lowered hemoglobin fluctuating between 100 and 110 g/L.
Adult
;
Antiviral Agents
;
therapeutic use
;
Female
;
Genotype
;
Hepacivirus
;
genetics
;
Hepatitis C, Chronic
;
drug therapy
;
Humans
;
Imidazoles
;
therapeutic use
;
Isoquinolines
;
therapeutic use
;
Sulfonamides
;
therapeutic use
2.Identification and expression analysis of flavonoid O -methyltransferases gene family in Artemisia argyi
Sai-nan PENG ; Yu-kun LI ; Dan-dan LUO ; Chang-jie CHEN ; Jia ZHOU ; Jia-yi LI ; Jia ZHENG ; Da-hui LIU ; Yu-huan MIAO
Acta Pharmaceutica Sinica 2023;57(4):1069-1078
italic>Artemisia argyi (
3.Protective Effect of Ficus pandurata Extract on Alcohol-induced Acute Liver Injury Base on Pyroptosis
Hui-ting FENG ; Wei-bo DAI ; Sha-sha BAI ; Chong-kun SHEN ; Wen-hao WEN ; Sai-nan CUI ; Yong-fei CUI ; Rong ZHANG ; Wei-wen PENG
Chinese Journal of Experimental Traditional Medical Formulae 2020;26(13):125-131
Objective:To study the protective effect of
4.Clinical and Laboratory Characteristics of Patients with Nontuberculous Mycobacterium Bloodstream Infection in a Tertiary Referral Hospital in Beijing, China.
Sai-Nan BIAN ; Li-Fan ZHANG ; Yue-Qiu ZHANG ; Qi-Wen YANG ; Peng WANG ; Ying-Chun XU ; Xiao-Chun SHI ; Xiao-Qing LIU ;
Chinese Medical Journal 2016;129(18):2220-2225
BACKGROUNDNontuberculous Mycobacterium (NTM) bloodstream infection (BSI) is relatively rare. We aimed in this study to evaluate the clinical characteristics, laboratory evaluation, and outcomes of patients with NTM BSI.
METHODSWe retrospectively reviewed the clinical records of inpatients with NTM BSI at our institution between January 2008 and January 2015 and recorded clinical parameters including age, gender, underlying disease, clinical manifestation, organs involved with NTM disease, species of NTM, laboratory data, treatment and outcome of these patients. We also reviewed the reported cases and case series of NTM BSI by searching PubMed, EMBASE, and Wanfang databases. Data of normal distribution were expressed by mean ± standard deviation (SD). Data of nonnormal distribution were expressed by median and interquartile range (IQR).
RESULTSAmong the ten patients with NTM BSI, the median age was 51 years (IQR 29-57 years) and three patients were males. Eight patients were immunocompromised, with underlying diseases including human immunodeficiency virus (HIV) infection (one patient), rheumatic diseases (two patients), breast cancer (one patient), myelodysplastic syndrome (two patients), and aplastic anemia (two patients). Other organ(s) involved were lung (two patients), endocardium (two patients), brain, spinal cord, and soft tissue (one each patient). The median lymphocyte was 0.66 × 109/L (IQR 0.24-1.93 × 109/L). The median cluster of differentiation 4 (CD4) cell count was 179/mm3 (IQR 82-619/mm3). Five patients died (three with hematological diseases, one with breast cancer, and one with rheumatic disease), three recovered, and two were lost to follow-up.
CONCLUSIONSWe reported all cases in our hospital diagnosed with bloodstream NTM infection that was rarely reported. In this group of patients, patients usually had a high fever and could have multiple organ involvements. All patients with poor prognosis had underlying diseases.
Adult ; Bacteremia ; diagnosis ; pathology ; China ; Female ; Humans ; Male ; Middle Aged ; Mycobacterium Infections, Nontuberculous ; diagnosis ; pathology ; Prognosis ; Retrospective Studies ; Tertiary Care Centers
5. Three-dimensional visual assessment and virtual reality study of centrally located hepatocellular carcinoma on the axis of blood vessels
Wen ZHU ; Songsheng HE ; Silue ZENG ; Peng ZHANG ; Jian YANG ; Nan XIANG ; Ning ZENG ; Yingfang FAN ; Sai WEN ; Chihua FANG ; Ke ZHANG
Chinese Journal of Surgery 2019;57(5):358-365
Objective:
To explore a novel method for preoperative precision assessment of centrally located hepatocellular carcinoma(HCC) with blood vessel as axis based on three-dimensional(3D) visualization and virtual reality(VR) technology and its application values.
Methods:
High-quality thin-layer enhanced CT data were collected from 20 patients with centrally located HCC who treated at First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University from March 2017 to August 2018 diagnosed by preoperative examination. There were 18 males and 2 females, aged 28 to 69 years, all of Child-Pugh grade A. First of all, 3D reconstruction was performed by a 3D visualization software; then, the reconstructed 3D image was imported into VR development engine for VR research; afterwards, the analysis and evaluation system with blood vessel as axis was established based on 3D visualization classification of centrally located HCC; therefore, the relationship of the tumor to its major peripheral blood vessels was accurately judged and the surgical planning was formulated. Two images were brought into the operating room for navigation in surgery. The assessments results of preoperative data (CT and (or) MRI) and three-dimensional visualization of blood vessels in VR environment were compared; the values of the preoperative and postoperative hemoglobin, serum albumin and bilirubin were recorded and compared. Chi-square test,